Application of physiologically active substances isolated from natural resources to pharmacological studies

被引:56
作者
Ohizumi, Y
机构
[1] Dept. of Pharmaceutical Molec. Biol., Faculty of Pharmaceutical Sciences, Tohoku University, Aoba-ku
关键词
physiologically active substance; pharmacological tool; ion channel; excitation-contraction coupling; protein phosphorylation;
D O I
10.1254/jjp.73.263
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Numerous neurotoxins that alter Na+-channel function have been shown to be useful tools for characterizing Na+ channels. Polypeptide blockers of voltage-dependent K+ channels (dendrotoxins, etc.) and Ca2+-activated K+ channels (apamine, etc.) have been studied extensively by numerous investigators. Peptide toxins, calciseptine and omega-conotoxins have been attracting much attention as inhibitors of L-type and N-type Ca2+ channels, respectively, while omega-conotoxins-MVIIC and omega-agatoxin IVA have been used as new types of Ca2+-channel blockers. Ryanodine and bromoeudistomin D analogues have been extensively used to elucidate Ca2+-release-channel functions and to purify its target protein. Polypeptide toxins (myotoxin cu, etc.) and macrolides (FK 506, etc.) are useful Ca2+ releasers with a novel mechanism, while natural products such as thapsigargin and gingerol have been used as modulators of Ca2+-pumping ATPase. Some modulators of the function of myosin (purealin, etc.) and actin (goniodomin A, etc.) have been demonstrated to be important chemical probes for understanding the physiological roles of the contractile proteins in structural changes and their interaction in muscle contraction. A large number of protein kinase inhibitors (staurosporine, etc.) and phosphatase inhibitors (okadaic acid, etc.) are widely used as first-choice reagents for studying protein phosphorylation. These natural products have become essential tools for studying the regulatory mechanism of cellular ion movements, muscle contraction and protein phosphorylation.
引用
收藏
页码:263 / 289
页数:27
相关论文
共 141 条
[1]   PROPERTIES OF THE BINDING-SITES OF [H-3] 9-METHYL-7-BROMOEUDISTOMIN-D IN BOVINE AORTIC SMOOTH-MUSCLE MICROSOMES [J].
ADACHI, M ;
FANG, YI ;
YAMAKUNI, T ;
KOBAYASHI, J ;
OHIZUMI, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (09) :771-773
[2]   TISSUE- AND SUBCELLULAR-DISTRIBUTION OF THE BINDING-SITE OF [H-3] 9-METHYL-7-BROMOEUDISTOMIN-D, A POTENT CAFFEINE-LIKE CA2+ RELEASER, IN RABBITS [J].
ADACHI, M ;
KAKUBARI, M ;
OHIZUMI, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (09) :774-776
[3]   THE SPECIFIC BINDING-SITE OF 9-[H-3]METHYL-7-BROMOEUDISTOMIN-D, A CAFFEINE-LIKE CA2+ RELEASER, IN LIVER-MICROSOMES IS DISTINCT FROM THAT IN SKELETAL SARCOPLASMIC-RETICULUM [J].
ADACHI, M ;
KAKUBARI, M ;
OHIZUMI, Y .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (03) :183-187
[4]  
AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362
[5]   CHARYBDOTOXIN BLOCK OF SINGLE CA-2+-ACTIVATED K+ CHANNELS - EFFECTS OF CHANNEL GATING, VOLTAGE, AND IONIC-STRENGTH [J].
ANDERSON, CS ;
MACKINNON, R ;
SMITH, C ;
MILLER, C .
JOURNAL OF GENERAL PHYSIOLOGY, 1988, 91 (03) :317-333
[6]  
AUGUSTE P, 1990, J BIOL CHEM, V265, P4753
[7]   MOLECULAR LOCALIZATION OF AN ION-BINDING SITE WITHIN THE PORE OF MAMMALIAN SODIUM-CHANNELS [J].
BACKX, PH ;
YUE, DT ;
LAWRENCE, JH ;
MARBAN, E ;
TOMASELLI, GF .
SCIENCE, 1992, 257 (5067) :248-251
[8]  
BENISHIN CG, 1988, MOL PHARMACOL, V34, P152
[9]   EFFECTS OF CIGUATOXIN ON CURRENT AND VOLTAGE CLAMPED FROG MYELINATED NERVE-FIBER [J].
BENOIT, E ;
LEGRAND, AM ;
DUBOIS, JM .
TOXICON, 1986, 24 (04) :357-364
[10]   MODE OF ACTION OF IBERIOTOXIN, A POTENT BLOCKER OF THE LARGE CONDUCTANCE CA-2+-ACTIVATED K+ CHANNEL [J].
CANDIA, S ;
GARCIA, ML ;
LATORRE, R .
BIOPHYSICAL JOURNAL, 1992, 63 (02) :583-590